Postgraduate Course: Translational Study - Innovation and Entrepreneurship Masterclass (Biz) (BUST11228)
Course Outline
| School | Business School |
College | College of Arts, Humanities and Social Sciences |
| Credit level (Normal year taken) | SCQF Level 11 (Postgraduate) |
Availability | Not available to visiting students |
| SCQF Credits | 20 |
ECTS Credits | 10 |
| Summary | The Translational Study - Innovation and Entrepreneurship Masterclass is a student-led, independent study course designed to promote student exposure to the challenges and opportunities associated with translating healthcare innovation into a market context. The course builds on the outcomes of the OPTIMA courses (i.e. Grand Challenge, Innovation-Driven Entrepreneurship (IDE), and Ethics and Regulatory Processes in Translating Innovation from Bench to Man), or other background experience considered relevant. Students will work in small teams to examine a specific innovation of healthcare technology. The projects will be related to actual scientific research results and will address real world considerations in commercialisation, drawing on guidance and input from leading edge researchers, entrepreneurs and other professionals, including colleagues from the Business School. |
| Course description |
This course is intended to deepen students' appreciation and skills in the real world implementation of healthcare innovation. Specifically, as part of an integrated studies PhD programme, the course aims:
a) To explore a set of innovations relevant to healthcare research, with relatively near-term product potential or short development timeframes.
b) To examine the need to conduct primary research on the industry and market relevant to the anticipated product. This will involve engagement with industry participants to better understand customer needs, product development requirements, manufacturing parameters, and distribution and support processes.
c) To identify the resources and processes necessary to bring the product to market.
d) To articulate and communicate the key lessons they are learning through these activities.
The course is designed as an integral part of the PhD with Integrated Studies offered by the OPTIMA CDT. It will also be able to accommodate other researchers/research students from the business school and other schools from the university with prior agreement. The current course builds on the overall programme of OPTIMA activity, in particular the Grand Challenge; the Innovation Driven Entrepreneurship course in year 1, and Ethics and Regulatory Processes in Translating Innovation from Bench to Man in year 2. In addition, it sensitises the students to the range of real world issues involved in commercialisation of healthcare technology and thus prepares them for further optional courses in innovation and entrepreneurship in year 3 (and 4).
The course is organised in three phases: 1) ideation, 2) development research, and 3) entry evaluation.
Phase 1, ideation, is a 3 week activity in which the teams explore a set of healthcare innovations relevant to their research studies. Design thinking and design thinking methods are introduced to the class. At the end of this phase teams will present their findings and will be assessed on the content and delivery of their presentations.
In Phase 2, development research, the teams will examine what primary research on the industry and market relevant to the anticipated product or process has been carried out. Students will be encouraged to engage with industry participants to better understand customer needs, product development requirements, manufacturing parameters, and distribution and support processes. This phase will occupy 4 weeks. At the end of this phase teams will submit a draft report focussing on issues of market feasibility for formative feedback.
Phase 3, entry evaluation, is a 3 week activity in which teams explore the resources and processes necessary to bring the healthcare innovation to market. At the end of the phase, teams will submit a formal written report presenting their analysis, including a critical appraisal of the commercialization path adopted. Teams will be assessed on the content and delivery of their report. In addition, teams will present their findings to a panel including industry representatives.
Each phase will be introduced by a formal overview lecture, accompanied by guest talks and seminars covering key issues and practices.
The experience and learnings acquired from the course will be consolidated through the submission of an individual Reflection on Learning paper, supported by a personal learning log which the students will maintain throughout the course activities.
|
Entry Requirements (not applicable to Visiting Students)
| Pre-requisites |
Students MUST have passed:
|
Co-requisites | |
| Prohibited Combinations | |
Other requirements | The course builds on the outcomes of the OPTIMA courses (i.e. Grand Challenge, Innovation-Driven Entrepreneurship (IDE), and Ethics and Regulatory Processes in Translating Innovation from Bench to Man). Please see information in 'Course Description '. |
Course Delivery Information
|
| Academic year 2019/20, Not available to visiting students (SS2)
|
Quota: None |
| Course Start |
Semester 2 |
Timetable |
Timetable |
| Learning and Teaching activities (Further Info) |
Total Hours:
200
(
Lecture Hours 5,
Seminar/Tutorial Hours 3,
Dissertation/Project Supervision Hours 8,
Fieldwork Hours 70,
Online Activities 20,
Formative Assessment Hours 20,
Summative Assessment Hours 10,
Other Study Hours 20,
Programme Level Learning and Teaching Hours 4,
Directed Learning and Independent Learning Hours
40 )
|
| Additional Information (Learning and Teaching) |
Other Study - face to face groupwork
|
| Assessment (Further Info) |
Written Exam
0 %,
Coursework
70 %,
Practical Exam
30 %
|
| Feedback |
a) Presentation at the end of the first, three week Ideation Phase, summarising their findings, in a formal session with detailed formative feedback provided from a panel of expert personnel. A summative assessment will also be carried forward (10%).
b) A draft written report, focusing on the market potential, will be submitted at the end of the second, four week Development Research Phase. This will constitute an initial draft for the final case appraisal, and will attract detailed formative feedback students in order to inform the further development of their project, without being allocated a mark at this stage. Written report of a maximum of 2,000 words, excluding supporting appendices.
c) A formal written report including consideration of all the issues involved in achieving commercialisation will be submitted at the end of the third, three week Entry Evaluation Phase. This will be marked by two members of the CDT, including the Business School course organiser, providing both formative and summative assessment (40%). The report will be accompanied by a formal presentation to a panel of expert personnel including industry representatives who will provide detailed formative feedback, as well as a final summative assessment (20%). PowerPoint or similar set of slides to be submitted and presented, within a time slot of 30 minutes, including Q&A.
d) As the above is group work, students will also provide a brief Individual Reflection on Learning paper, based on a Personal Learning Log, on an individual basis. This Log will cover the students' experience in working in teams and will provide a critical assessment of their own contribution, as well as summarising the overall translational process. This will be marked by two members of the CDT, including the Business School representative, and detailed formative feedback will be provided to the students in order to support their further development through their doctoral studies (30%). Written paper of 500 words Reflection on Learning will be submitted, supported by a Personal Learning Log with a maximum of a half page of commentary per week in Appendix.
|
| No Exam Information |
Learning Outcomes
On completion of this course, the student will be able to:
- Work effectively in teams and understand the various roles that individuals can play in teams, including leadership and taking responsibility for individual contributions.
- Understand the specific challenges associated with translating a healthcare technology and innovation into a commercial context, and develop a critical appreciation about how the available theories, principles and concepts in the field of innovation and entrepreneurship can throw light on the practical issues confronted.
- Explain the imperatives for primary research on user needs, market opportunities and new product requirements, using an appropriate range of theories, specialised techniques and skills.
- Describe the general stages of technology commercialisation, informed by developments at the forefront of academic and industry experience, including a critical awareness of different organisational forms and resource requirements.
- Communicate the results of market and industry research using appropriate methods to both scientific and business audiences and critically assess the potential commercial value of a novel innovation for a specific market need, taking account of the need to make informed and ethically sound judgements in the face of inconsistent and incomplete information.
|
Reading List
James Barlow (2017) Managing Innovation in Healthcare.
More detailed information on suggested reading materials will be provided during the course.
|
Additional Information
| Graduate Attributes and Skills |
Not entered |
| Keywords | Innovation,Entrepreneurship |
Contacts
| Course organiser | Dr Fumi Kitagawa
Tel: (0131 6)50 8068
Email: Fumi.Kitagawa@ed.ac.uk |
Course secretary | Mrs Lindsey Singleton
Tel: (0131 6)51 5307
Email: Lindsey.Singleton@ed.ac.uk |
|
|
University Homepage